Immunity
. 2021 Apr 22;S1074-7613(21)00139-4.
doi: 10.1016/j.immuni.2021.04.002. Online ahead of print.
Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections
Hani Harb 1 , Mehdi Benamar 1 , Peggy S Lai 2 , Paola Contini 3 , Jason W Griffith 2 , Elena Crestani 1 , Klaus Schmitz-Abe 1 , Qian Chen 1 , Jason Fong 1 , Luca Marri 4 , Gilberto Filaci 5 , Genny Del Zotto 6 , Novalia Pishesha 7 , Stephen Kolifrath 7 , Achille Broggi 1 , Sreya Ghosh 1 , Metin Yusuf Gelmez 8 , Fatma Betul Oktelik 8 , Esin Aktas Cetin 8 , Ayca Kiykim 9 , Murat Kose 10 , Ziwei Wang 1 , Ye Cui 1 , Xu G Yu 11 , Jonathan Z Li 12 , Lorenzo Berra 13 , Emmanuel Stephen-Victor 1 , Louis-Marie Charbonnier 1 , Ivan Zanoni 1 , Hidde Ploegh 7 , Gunnur Deniz 8 , Raffaele De Palma 14 , Talal A Chatila 15
Affiliations
- PMID: 33915108
- PMCID: PMC8080416
- DOI: 10.1016/j.immuni.2021.04.002
Abstract
A cardinal feature of COVID-19 is lung inflammation and respiratory failure. In a prospective multi-country cohort of COVID-19 patients, we found that increased Notch4 expression on circulating regulatory T (Treg) cells was associated with disease severity, predicted mortality, and declined upon recovery. Deletion of Notch4 in Treg cells or therapy with anti-Notch4 antibodies in conventional and humanized mice normalized the dysregulated innate immunity and rescued disease morbidity and mortality induced by a synthetic analog of viral RNA or by influenza H1N1 virus. Mechanistically, Notch4 suppressed the induction by interleukin-18 of amphiregulin, a cytokine necessary for tissue repair. Protection by Notch4 inhibition was recapitulated by therapy with Amphiregulin and, reciprocally, abrogated by its antagonism. Amphiregulin declined in COVID-19 subjects as a function of disease severity and Notch4 expression. Thus, Notch4 expression on Treg cells dynamically restrains amphiregulin-dependent tissue repair to promote severe lung inflammation, with therapeutic implications for COVID-19 and related infections.
Keywords: COVID-19; IL-18; IL-6; Notch4; SARS-CoV-2; amphiregulin; influenza; regulatory T cells.